Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
CANCER:
Soft Tissue Sarcoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Sarcoma (572
)
Osteosarcoma (51
)
Liposarcoma (43
)
Ewing Sarcoma (40
)
Fibrosarcoma (33
)
Leiomyosarcoma (30
)
Rhabdomyosarcoma (27
)
Uterine Corpus Leiomyosarcoma (20
)
Kaposi Sarcoma (13
)
Neurofibrosarcoma (12
)
Spindle Cell Sarcoma (8
)
Sarcoma (572
)
Osteosarcoma (51
)
Liposarcoma (43
)
Ewing Sarcoma (40
)
Fibrosarcoma (33
)
Leiomyosarcoma (30
)
Rhabdomyosarcoma (27
)
Uterine Corpus Leiomyosarcoma (20
)
Kaposi Sarcoma (13
)
Neurofibrosarcoma (12
)
Spindle Cell Sarcoma (8
)
›
Associations
(126)
Heatmap
News
Twitter
Trials
Reset Filters
Veri cancer hierarchy
x
x
x
x
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
envafolimab
Sensitive: B - Late Trials
Tracon Pharmaceuticals Press Release - 1 week (New B)
envafolimab
Sensitive
:
B
Tracon Pharmaceuticals Press Release - 1wk
envafolimab
Sensitive: B - Late Trials
Tracon Pharmaceuticals Press Release - 1 week
envafolimab
Sensitive
:
B
Tracon Pharmaceuticals Press Release - 1 week - (New B)
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
olaratumab
Sensitive: A1 - Approval
olaratumab
Sensitive
:
A1
olaratumab
Sensitive: A1 - Approval
olaratumab
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
trabectedin
Sensitive: A1 - Approval
trabectedin
Sensitive
:
A1
trabectedin
Sensitive: A1 - Approval
trabectedin
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
pazopanib
Sensitive: A1 - Approval
pazopanib
Sensitive
:
A1
pazopanib
Sensitive: A1 - Approval
pazopanib
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
tazemetostat
Sensitive: A1 - Approval
tazemetostat
Sensitive
:
A1
tazemetostat
Sensitive: A1 - Approval
tazemetostat
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
doxorubicin hydrochloride
Sensitive: A1 - Approval
doxorubicin hydrochloride
Sensitive
:
A1
doxorubicin hydrochloride
Sensitive: A1 - Approval
doxorubicin hydrochloride
Sensitive
:
A1
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
ifosfamide + epirubicin + mesna
Sensitive: A2 - Guideline
ifosfamide + epirubicin + mesna
Sensitive
:
A2
ifosfamide + epirubicin + mesna
Sensitive: A2 - Guideline
ifosfamide + epirubicin + mesna
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
AIM
Sensitive: A2 - Guideline
AIM
Sensitive
:
A2
AIM
Sensitive: A2 - Guideline
AIM
Sensitive
:
A2
NTRK3 fusion
Soft Tissue Sarcoma
NTRK3 fusion
Soft Tissue Sarcoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
GT
Sensitive: A2 - Guideline
GT
Sensitive
:
A2
GT
Sensitive: A2 - Guideline
GT
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
ifosfamide
Sensitive: A2 - Guideline
ifosfamide
Sensitive
:
A2
ifosfamide
Sensitive: A2 - Guideline
ifosfamide
Sensitive
:
A2
NTRK1 fusion
Soft Tissue Sarcoma
NTRK1 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Soft Tissue Sarcoma
NTRK3 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Soft Tissue Sarcoma
NTRK2 fusion
Soft Tissue Sarcoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
gemcitabine + dacarbazine
Sensitive: A2 - Guideline
gemcitabine + dacarbazine
Sensitive
:
A2
gemcitabine + dacarbazine
Sensitive: A2 - Guideline
gemcitabine + dacarbazine
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
cediranib
Sensitive: A2 - Guideline
cediranib
Sensitive
:
A2
cediranib
Sensitive: A2 - Guideline
cediranib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
ALK translocation
Soft Tissue Sarcoma
ALK translocation
Soft Tissue Sarcoma
crizotinib
Sensitive: A2 - Guideline
crizotinib
Sensitive
:
A2
crizotinib
Sensitive: A2 - Guideline
crizotinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
regorafenib
Sensitive: A2 - Guideline
regorafenib
Sensitive
:
A2
regorafenib
Sensitive: A2 - Guideline
regorafenib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
ifosfamide + pegylated liposomal doxorubicin
Sensitive: A2 - Guideline
ifosfamide + pegylated liposomal doxorubicin
Sensitive
:
A2
ifosfamide + pegylated liposomal doxorubicin
Sensitive: A2 - Guideline
ifosfamide + pegylated liposomal doxorubicin
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
dacarbazine
Sensitive: A2 - Guideline
dacarbazine
Sensitive
:
A2
dacarbazine
Sensitive: A2 - Guideline
dacarbazine
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
gemcitabine + vinorelbine tartrate
Sensitive: A2 - Guideline
gemcitabine + vinorelbine tartrate
Sensitive
:
A2
gemcitabine + vinorelbine tartrate
Sensitive: A2 - Guideline
gemcitabine + vinorelbine tartrate
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
gemcitabine
Sensitive: A2 - Guideline
gemcitabine
Sensitive
:
A2
gemcitabine
Sensitive: A2 - Guideline
gemcitabine
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
MAID
Sensitive: A2 - Guideline
MAID
Sensitive
:
A2
MAID
Sensitive: A2 - Guideline
MAID
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
epirubicin
Sensitive: A2 - Guideline
epirubicin
Sensitive
:
A2
epirubicin
Sensitive: A2 - Guideline
epirubicin
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
Tyrosine kinase inhibitor
Sensitive: A2 - Guideline
Tyrosine kinase inhibitor
Sensitive
:
A2
Tyrosine kinase inhibitor
Sensitive: A2 - Guideline
Tyrosine kinase inhibitor
Sensitive
:
A2
NTRK1 fusion
Soft Tissue Sarcoma
NTRK1 fusion
Soft Tissue Sarcoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
NTRK2 fusion
Soft Tissue Sarcoma
NTRK2 fusion
Soft Tissue Sarcoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
eribulin mesylate
Sensitive: A2 - Guideline
eribulin mesylate
Sensitive
:
A2
eribulin mesylate
Sensitive: A2 - Guideline
eribulin mesylate
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
gemcitabine + docetaxel
Sensitive: A2 - Guideline
gemcitabine + docetaxel
Sensitive
:
A2
gemcitabine + docetaxel
Sensitive: A2 - Guideline
gemcitabine + docetaxel
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive: A2 - Guideline
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive
:
A2
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive: A2 - Guideline
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
AD
Sensitive: A2 - Guideline
AD
Sensitive
:
A2
AD
Sensitive: A2 - Guideline
AD
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
